Second Department of Obstetrics and Gynecology, University of Athens, Aretaieion Hospital, Athens, Greece.
Gynecol Endocrinol. 2013 Feb;29(2):98-100. doi: 10.3109/09513590.2012.730578. Epub 2012 Oct 30.
One of the most serious complications of assisted reproduction techniques is ovarian hyperstimulation syndrome (OHSS). OHSS not only increases morbidity and mortality in IFV cycles, but also causes significant other problems, as cancelled in vitro fertilization (IVF) cycles, prolonged hospitalization, causing emotional and sociofinancial consequences. Several treatments for OHSS have been proposed and among these Cabergoline (Cb2). Despite the above-mentioned beneficial effect, Cb2 has not been widely used in everyday's clinical practice. With our study, we try to review all studies with strong evidence examining Cb2 use for OHSS prevention.
辅助生殖技术最严重的并发症之一是卵巢过度刺激综合征（OHSS）。OHSS 不仅增加了 IFV 周期的发病率和死亡率，还会导致其他重大问题，如取消体外受精（IVF）周期、延长住院时间、引起情绪和社会经济后果。已经提出了几种治疗 OHSS 的方法，其中包括卡麦角林（Cb2）。尽管有上述有益作用，但 Cb2 在日常临床实践中并未得到广泛应用。通过我们的研究，我们试图回顾所有具有强有力证据的研究，以检查 Cb2 用于预防 OHSS 的使用情况。
